DJIA 17,745.98 -5.41 -0.03%
NASDAQ 5,128.79 17.05 0.33%
S&P 500 2,108.63 0.06 0.00%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

135.46 9.84 (7.83%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $135.46 7.83%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $126.09
Previous Close $125.62
Daily Range $121.15 - $135.90
52-Week Range $84.41 - $137.50
Market Cap $33.0B
P/E Ratio -42.30
Dividend (Yield) $0.00 (0.0%)
Volume 3,099,814
Average Daily Volume 1,685,017
Current FY EPS -$2.00

Sector

Healthcare

Industry

Drug Makers

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary Rss Feed

Vertex Pharmaceuticals Rolls Along

Solid quarter, but Orkambi sales in future quarters will dictate the biotech’s fate.

Vertex Posts Wider Y/Y Loss but Raises Kalydeco Outlook - Analyst Blog

3 Drugs Stocks Pushing Industry Growth

Vertex Pharmaceuticals (VRTX) Earnings Report: Q2 2015 Conference Call Transcript

Vertex Pharmaceuticals (VRTX) Jeffrey M. Leiden on Q2 2015 Results - Earnings Call Transcript

Trade-Ideas: Vertex Pharmaceuticals (VRTX) Is Today's Post-Market Leader Stock

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst Blog

Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 66.7% Follow-Through Indicator, 3.8%

Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 66.7% Follow-Through Indicator, 3.8% Sensitive

The Secret to Vertex Pharmaceuticals' Success

Originally set out to treat the hepatitis C market, Vertex has successfully pivoted its focus to the cystic fibrosis market instead, where it looks poised for strong growth.

Will Vertex (VRTX) Surprise with a Lower Loss in Q2? - Analyst Blog

See More VRTX News...

VRTX's Top Competitors

VRTX $135.46 (7.83%)
Current stock: VRTX
AMGN $171.69 (0.13%)
Current stock: AMGN
GILD $117.90 (1.89%)
Current stock: GILD
BIIB $317.00 (1.17%)
Current stock: BIIB